Tadalafil, known commercially as Cialis, is typically prescribed for erectile dysfunction but is generating interest in other sectors as a potential longevity drug. Online clinics and influential personalities suggest it could benefit the cardiovascular system, the brain, and athletic performance. However, its approval doesn’t cover preventing heart attacks, strokes, or extending life.
Potential in Preventive Health
Experts in cardiology and men’s health are considering the possibility of tadalafil playing a role in preventive health. Dr. Robert Kloner of the Huntington Medical Research Institute reflects, “It’s a serious area of discussion.” With cardiovascular disease as a leading cause of death, understanding tadalafil’s benefits is crucial.
Research and Observational Studies
Tadalafil, similar to sildenafil (Viagra), lasts longer but both have shown promising results in large observational studies. Such studies report that men using these drugs have reduced rates of cardiovascular disease, lower mortality rates, and a decreased likelihood of dementia. Although these studies show associations, they don’t confirm that tadalafil is the cause.
Online Longevity Conversation
The discussion on tadalafil for longevity has extended to well-known figures, including Stanford’s Andrew Huberman and tech mogul Bryan Johnson, advocating its use beyond sexual enhancement. Even women like Kristi Sawicki, who has a background in molecular oncology, see potential benefits.
Studies and Mechanisms
While primarily used for erectile dysfunction, tadalafil and sildenafil are approved for pulmonary hypertension and symptoms of enlarged prostate. These medications, known as PDE-5 inhibitors, work by sustaining a signaling molecule, relaxing muscles and widening blood vessels, thus enhancing blood flow and potentially reducing inflammation.
Studies leveraging medical records show substantial effects. An analysis led by Kloner found significant reductions in cardiovascular mortality rates among men using tadalafil. Research has also noted a reduced risk of dementia.
Caution and Lack of Prospective Studies
Despite promising findings, researchers acknowledge the necessity of randomized trials to validate associations observed in retrospective studies. Unknown factors may contribute to the reduced mortality and disease prevalence among users.
Kloner also emphasizes insufficient research on the effects in women. Pharmaceutical companies’ lack of motivation to fund costly studies for generics further complicates matters.
Marketing and Controversy
Online clinics promote tadalafil for longevity, despite lacking conclusive evidence from randomized trials. There’s concern about potential harms not evidenced by current data.
Expert Panel Review
The Princeton Consensus Panel, focusing on men’s health and cardiovascular issues, reconsidered tadalafil’s broader use. Some members hesitated due to the absence of randomized trials, but existing research convinced them to support its use in men at risk of cardiovascular disease.
Dr. Martin Miner, who co-chaired the meeting, stated, “This is not for all men,” highlighting its potential utility for those with higher risk.